8-K - Protagonist Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Regulation Fd

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

. Regulation FD Disclosure. On January 12, 2026, Protagonist Therapeutics, Inc. (the “Company”) made available an updated corporate presentation. A copy of the

Regulation Fd

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Protagonist Therapeutics, Inc. Corporate Presentation, as of January 12, 2026. 104

Exhibits Only

Source Document

Exhibits (2)

8-K

FORM 8-K

99.1

EXHIBIT 99.1